The DOI matches its Crossref record; 163 of the 166 references it cites were found in a registry or an index.
A decade of exploring the cancer epigenome—biological and translational implications
Open accessAbstract
The past decade has highlighted the central role of epigenetic processes in cancer causation, progression and treatment. Next-generation sequencing is providing a window for visualizing the human epigenome and how it is altered in cancer. This view provides many surprises, including linking epigenetic abnormalities to mutations in genes that control DNA methylation, the packaging and the function of DNA in chromatin, and metabolism. Epigenetic alterations are leading candidates for the development of specific markers for cancer detection, diagnosis and prognosis. The enzymatic processes that control the epigenome present new opportunities for deriving therapeutic strategies designed to reverse transcriptional abnormalities that are inherent to the cancer epigenome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Conversely, disruption of chromosomal topology and oncogene insulation may be more generally relevant to methylator phenotypes observed in colorectal and renal cell carcinomas, leukemia and other malignancies28.”
From Insulator dysfunction and oncogene activation in IDH mutant gliomas (2016) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies showed that enhanced histone acetylation induced by HDACi allowed the overexpression of genes involved in cell cycle arrest such as cyclin-dependent kinase inhibitors or the growth arrest and DNA damage-inducible protein GADD45 gene family (11, 28, 40, 45-49).”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Insulator dysfunction may also be accompanied by promoter silencing events28,29, and by alterations to other pathways affected by 2-HG7,30.”
From Insulator dysfunction and oncogene activation in IDH mutant gliomas (2016) · cites this paper as [28]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Among them, novel selective benzamide-based HDAC1/2 inhibitors have been described that exhibit greater than 100-fold selectivity relative to other HDACs (11, 28).”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [11]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“It has previously been shown that HDAC inhibitors such as SAHA and MS-275 promote cell cycle arrest and apoptosis”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [11]
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Among activated genes that subside with pulsed HDACi administration are genes known to be powerful effectors of cell cycle arrest in multiple cell types and may promote apoptosis (11, 50).”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [11]
Experimental — accuracy not yet measuredIn the citing paper
“Three general processes have major effects on cancer initiation and progression. First, discrete somatic mutations lead to tumor suppressor loss-of-function and oncoprotein gain-of-function [1]; second, epigenetic alterations change patterns of gene expression [2]; and third, alterations in the tumor microenvironment also lead to broad changes in gene expression [3].”
From The hypoxic tumor microenvironment: A driving force for breast cancer progression (2016) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Self-citationA bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Gupta, R. A., Shah, N., Wang, K., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M.-C., Hung, T., Argani, P., Rinn, J. L., et al. (2010) · Nature · doi:10.1038/nature08975 · Cited by 5,205
Flagged first, then by citations
3 of the 166 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Allis, C., Jenuwein, T. & Reinberg, D. Epigenetics (ed. Caparros, M.) (Cold Spring Harbor Laboratory Press, 2007).
- Allis, C. D., Jenuwein, T, Reinberg, D. Overview and concepts (Cold Spring Harbor Laboratory Press, New York, 2007).
- Gilbert, M. R. et al. in ASCO Annual Meeting 2011 Abstr. 2006. (University of Texas M. D. Anderson Cancer Center, Chicago, 2011).
Cited by
Sorted by citations
Items 701–800 of 1,001
Ding, S., Khoury-Hanold, W., Iwasaki, A., & Robek, M. D. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001758 · Cited by 59
Keeley, B. P., Stark, A., Pisanic, T. R., Kwak, R., Zhang, Y., Wrangle, J. M., Baylin, S. B., Herman, J. G., Ahuja, N., Brock, M. V., et al. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.07.023 · Cited by 56
Self-citationde Silva, S., Wang, F., Hake, T. S., Porcu, P., Wong, H. K., & Wu, L. J. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.311 · Cited by 58
Sánchez-Vega, F., Gotea, V., Petrykowska, H. M., Margolin, G., Krivak, T. C., DeLoia, J. A., Bell, D. W., & Elnitski, L. L. (2013) · Epigenetics · doi:10.4161/epi.26701 · Cited by 56
Epigenetic markers of prostate cancer in plasma circulating DNA
Cortese, R., Kwan, A., Lalonde, E., Bryzgunova, O. E., Bondar, A. A., Wu, Y., Gordevičius, J., Park, M., Oh, G., Kaminsky, Z. A., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds192 · Cited by 58
DNA methylation and hormone receptor status in breast cancer
Benevolenskaya, E. V., Islam, A. B. M. M. K., Ahsan, H., Kibriya, M. G., Jasmine, F., Wolff, B., Al‐Alem, U., Wiley, E. L., Kajdacsy‐Balla, A., Macias, V., et al. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0184-7 · Cited by 57
Metabolic interactions with cancer epigenetics
Gao, X., Reid, M. A., Kong, M., & Locasale, J. W. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.09.001 · Cited by 55
UV-induced damage to DNA: effect of cytosine methylation on pyrimidine dimerization
Martínez‐Fernández, L., Bányász, Á., Esposito, L., Markovitsi, D., & Improta, R. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.21 · Cited by 56
Liao, P., Ostrom, Q. T., Stetson, L. C., & Barnholtz‐Sloan, J. S. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy003 · Cited by 54
The Epigenomics of Pituitary Adenoma
Hauser, B. M., Lau, A., Gupta, S., Bi, W. L., & Dunn, I. F. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00290 · Cited by 56
Therapeutic Cancer Vaccines—T Cell Responses and Epigenetic Modulation
Kartikasari, A. E. R., Prakash, M. D., Cox, M., Wilson, K., Boer, J. C., Cauchi, J. A., & Plebanski, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03109 · Cited by 54
The Role of Chromatin Remodeling in Medulloblastoma
Jones, D., Northcott, P. A., Kool, M., & Pfister, S. M. (2013) · Brain Pathology · doi:10.1111/bpa.12019 · Cited by 58
Perspectives on natural product epigenetic modulators in chemical biology and medicine
Cherblanc, F., Davidson, R. W. M., Fruscia, P. D., Srimongkolpithak, N., & Fuchter, M. J. (2013) · Natural Product Reports · doi:10.1039/c3np20097c · Cited by 56
Cancer Stem Cells in Pediatric Sarcomas
Cruz, F. S. D. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00168 · Cited by 55
Nickel and Epigenetic Gene Silencing
Sun, H., SHAMY, M. Y., & Costa, M. (2013) · Genes · doi:10.3390/genes4040583 · Cited by 57
MacroH2A – An epigenetic regulator of cancer
Cantariño, N., Douet, J., & Buschbeck, M. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.022 · Cited by 57
The Cancer Epigenome: Its Origins, Contributions to Tumorigenesis, and Translational Implications
Baylin, S. B. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201201-001ms · Cited by 55
Self-citationWeichenhan, D., & Plass, C. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt348 · Cited by 58
Kirby, M. K., Ramaker, R. C., Roberts, B. S., Lasseigne, B. N., Gunther, D. S., Burwell, T. C., Davis, N. S., Gulzar, Z. G., Absher, D., Cooper, S. J., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3252-2 · Cited by 55
Mismatch Repair Proteins Initiate Epigenetic Alterations during Inflammation-Driven Tumorigenesis
Maiuri, A. R., Peng, M., Podicheti, R., Sriramkumar, S., Kamplain, C. M., Rusch, D. B., Shields, C. E. D., Sears, C. L., & O’Hagan, H. M. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0056 · Cited by 57
Liquid biopsies: DNA methylation analyses in circulating cell-free DNA
Zeng, H., He, B., Yi, C., & Peng, J. (2018) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2018.02.007 · Cited by 58
Epigenetic regulation in the pathogenesis of non-melanoma skin cancer
Kashyap, M. P., Sinha, R., Mukhtar, M. S., & Athar, M. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.009 · Cited by 57
Genome-Wide Methylation Analyses in Glioblastoma Multiforme
Lai, R. K., Chen, Y., Guan, X., Nousome, D., Sharma, C., Canoll, P., Bruce, J., Sloan, A. E., Cortes, E., Vonsattel, J.-P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089376 · Cited by 54
Genetic Events That Shape the Cancer Epigenome
Ryan, R. J. H., & Bernstein, B. (2012) · Science · doi:10.1126/science.1223730 · Cited by 55
MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine Starvation
Hansen, L. J., Sun, R., Yang, R. R., Singh, S. X., Chen, L. H., Pirozzi, C. J., Moure, C. J., Hemphill, C., Carpenter, A. B., Healy, P. N., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-1010 · Cited by 56
ARID1A in cancer: Friend or foe?
Fontana, B., Gallerani, G., Salamon, I., Pace, I., Roncarati, R., & Ferracin, M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1136248 · Cited by 58
What are we learning from the cancer genome?
Collisson, E. A., Cho, R. J., & Gray, J. W. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.159 · Cited by 55
Chen, C., Lee, K., Pai, M.-Y., Chu, P., Hsu, C., Chiu, C.-C., Chen, L., Chang, J., Hsiao, S., & Leu, Y. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0248-3 · Cited by 57
Epigenetic Research in Cancer Epidemiology: Trends, Opportunities, and Challenges
Verma, M., Rogers, S. D., Divi, R. L., Schully, S. D., Nelson, S. A., Su, L. J., Ross, S. A., Pilch, S., Winn, D. M., & Khoury, M. J. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0573 · Cited by 54
Sierra, M., Fernández, A. F., & Fraga, M. F. (2015) · Current Genomics · doi:10.2174/1389202916666150817203459 · Cited by 56
DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas
Malouf, G. G., Su, X., Zhang, J., Creighton, C. J., Ho, T. H., Lu, Y., Raynal, N. J. ‐., Karam, J. A., Tamboli, P., Allanick, F., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1217 · Cited by 55
Bioinformatics Tools for Genome-Wide Epigenetic Research
Angarica, V. E., & del Sol, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_25 · Cited by 56
Target specificity of mammalian DNA methylation and demethylation machinery
Ravichandran, M., Jurkowska, R. Z., & Jurkowski, T. P. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob02574b · Cited by 62
RNA Modifications: Reversal Mechanisms and Cancer
Thapar, R., Bacolla, A., Oyeniran, C., Brickner, J. R., Chinnam, N. B., Mosammaparast, N., & Tainer, J. A. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00949 · Cited by 54
Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management
Chan, T. A.-T., Ho, A. S., & Turcan, Ş. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s34680 · Cited by 54
Sin, T. K., Mokhtar, N. M., Hassan, N. Z. A., Sagap, I., Rose, I. M., Harun, R., & Jamal, R. A. (2015) · Oncology Reports · doi:10.3892/or.2015.3993 · Cited by 53
A Meta Analysis of Pancreatic Microarray Datasets Yields New Targets as Cancer Genes and Biomarkers
Goonesekere, N. C. W., Wang, X., Ludwig, L., & Guda, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093046 · Cited by 54
Lai, N., Chou, J., Chen, G. C. W., Liu, S.-Q., Lu, M., & Chan, M. W. Y. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3242-2 · Cited by 53
Tiffen, J. C., Wilson, S. P., Gallagher, S. J., Hersey, P., & Filipp, F. V. (2016) · Neoplasia · doi:10.1016/j.neo.2016.01.003 · Cited by 54
Epigenetics: A key paradigm in reproductive health
Bunkar, N., Pathak, N., Lohiya, N. K., & Mishra, P. K. (2016) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2016.43.2.59 · Cited by 52
Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma
Gong, F., Guo, Y., Niu, Y., Jin, J., Zhang, X., Shi, X., Zhang, L., Li, R., Chen, L., & Ma, R. Z. (2016) · Oncotarget · doi:10.18632/oncotarget.13324 · Cited by 53
Barbano, R., Pasculli, B., Rendina, M., Fontana, A., Fusilli, C., Copetti, M., Castellana, S., Valori, V. M., Morritti, M. G., Graziano, P., et al. (2017) · Scientific Reports · doi:10.1038/srep45283 · Cited by 53
Su, X., Zhang, J., Mouawad, R., Compérat, É., Morgan Rouprêt, A., Allanic, F., Parra, J., Bitker, M., Thompson, E. J., Gowrishankar, B., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0143 · Cited by 56
Estimation of chimpanzee age based on DNA methylation
Ito, H., Udono, T., Hirata, S., & Inoue‐Murayama, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-28318-9 · Cited by 53
Early Epigenetic Markers for Precision Medicine
Dumitrescu, R. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8751-1_1 · Cited by 53
Nabilsi, N. H., Deleyrolle, L. P., Darst, R. P., Riva, A., Reynolds, B. A., & Kladde, M. P. (2013) · Genome Research · doi:10.1101/gr.161737.113 · Cited by 53
Narayan, G., Xie, D., Freddy, A. J., Ishdorj, G., Do, C., Satwani, P., Liyanage, H., Clark, L. N., Kisselev, S., Nandula, S. V., et al. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22098 · Cited by 52
Epigenetics, TET proteins, and hypoxia in epithelial-mesenchymal transition and tumorigenesis
Chen, H., & Wu, K. (2016) · Biomedicine · doi:10.7603/s40681-016-0001-9 · Cited by 53
Curry, E. W., Zeller, C., Masrour, N., Patten, D. K., Gallon, J., Wilhelm-Benartzi, C. S., Ghaem‐Maghami, S., Bowtell, D. D. L., & Brown, R. E. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1650 · Cited by 54
Xiao, C., Fu, X., Wang, Y., Liu, H., Jiang, Y., Zhao, Z., & You, F. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243812 · Cited by 53
Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma
Chai, P., Jia, R., Li, Y., Zhou, C., Gu, X., Yang, L., Shi, H., Tian, H., Lin, H., Yu, J., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101030 · Cited by 56
Role of somatic cancer mutations in human protein lysine methyltransferases
Kudithipudi, S., & Jeltsch, A. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.08.002 · Cited by 55
Sánchez-Vega, F., Gotea, V., Margolin, G., & Elnitski, L. L. (2015) · Epigenetics & Chromatin · doi:10.1186/s13072-015-0007-7 · Cited by 53
Heterogeneity of Neoplastic Stem Cells: Theoretical, Functional, and Clinical Implications
Valent, P., Bonnet, D. A., Wöhrer, S., Andreeff, M., Copland, M., Chomienne, C., & Eaves, C. J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3678 · Cited by 52
Noncoding RNA and colorectal cancer: its epigenetic role
Kita, Y., Yonemori, K., Osako, Y., Baba, K., Mori, S., Maemura, K., & Natsugoe, S. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.66 · Cited by 53
Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma
Nakaoka, T., Saito, Y., & Saito, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061111 · Cited by 51
Kernaleguen, M., Daviaud, C., Shen, Y., Bonnet, É., Renault, V., Deleuze, J., Mauger, F., & Tost, J. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7774-1_18 · Cited by 53
Next generation sequencing-based emerging trends in molecular biology of gastric cancer.
Verma, R., & Sharma, P. C. (2018) · PubMed Central · Cited by 52
The role of DNA-demethylating agents in cancer therapy
Mehdipour, P., Murphy, T., & Carvalho, D. D. D. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107416 · Cited by 55
Ling, B., Liao, X., Huang, Y., Liang, L., Jiang, Y., Pang, Y., & Qi, G. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4926 · Cited by 52
Wang, J., Yang, J., Li, D., & Li, J. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188454 · Cited by 53
Epigenetic Alterations in Pancreatic Cancer Metastasis
Wang, S. S., Xu, J., Ji, K. Y., & Hwang, C. (2021) · Biomolecules · doi:10.3390/biom11081082 · Cited by 50
Grady, W. M. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.02.006 · Cited by 52
Epigenetic Dysregulations in Arsenic-Induced Carcinogenesis
Islam, R., Zhao, L., Wang, Y.-F., Lu-Yao, G. L., & Liu, L.-Z. (2022) · Cancers · doi:10.3390/cancers14184502 · Cited by 55
Arai, E., Gotoh, M., Tian, Y., Sakamoto, H., Ono, M., Matsuda, A., Takahashi, Y., Miyata, S., Totsuka, H., Chiku, S., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29630 · Cited by 50
Tarabichi, M., Antoniou, A., Saiselet, M., Pita, J. M. G., Andry, G., Dumont, J. E., Detours, V., & Maenhaut, C. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9431-y · Cited by 51
Akers, S. N., Moysich, K. B., Zhang, W., Lai, G. C., Miller, A., Lele, S., Odunsi, K. O., & Karpf, A. R. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.12.024 · Cited by 51
Lee, S., Muench, M. O., Fomin, M. E., Xiao, J., Zhou, M., de Smith, A. J., Martín-Subero, J. I., Heath, S. C., Houseman, E. A., Roy, R., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv103 · Cited by 50
Lee, S., & Wiemels, J. L. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1038 · Cited by 51
Rea, M., Eckstein, M., Eleazer, R., Smith, C. N., & Fondufe‐Mittendorf, Y. N. (2017) · Scientific Reports · doi:10.1038/srep41474 · Cited by 49
Ambrosio, S., Saccà, C. D., & Majello, B. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.07.001 · Cited by 52
Single cell epigenome sequencing technologies
Wen, L., & Tang, F. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.09.002 · Cited by 51
Wang, N., Li, Y., Wei, J., Pu, J., Liu, R., Yang, Q., Guan, H., Shi, B., Hou, P., & Ji, M. (2018) · Thyroid · doi:10.1089/thy.2018.0312 · Cited by 51
Developmental origins and oncogenic pathways in malignant brain tumors
Lu, Q. R., Qian, L., & Zhou, X. (2019) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.342 · Cited by 55
The emerging role of mediator complex subunit 12 in tumorigenesis and response to chemotherapeutics
Zhang, S., O'Regan, R. M., & Xu, W. (2019) · Cancer · doi:10.1002/cncr.32672 · Cited by 50
Translational Cancer Research: Balancing Prevention and Treatment to Combat Cancer Globally
Wild, C. P., Bucher, J. R., de Jong, B. W. D., Dillner, J., von Gertten, C., Groopman, J. D., Herceg, Z., Holmes, E. C., Holmila, R. J., Olsen, J. H., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju353 · Cited by 50
Pharmacologic Induction of BRCAness in BRCA-Proficient Cancers: Expanding PARP Inhibitor Use
Abbotts, R., Dellomo, A. J., & Rassool, F. V. (2022) · Cancers · doi:10.3390/cancers14112640 · Cited by 54
Epigenetic targets and drug discovery
Liu, Y., Liu, K., Su, Q., Xu, C., & Min, J. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.03.007 · Cited by 51
Folate, colorectal cancer and the involvement of DNA methylation
Williams, E. A. (2012) · Proceedings of The Nutrition Society · doi:10.1017/s0029665112000717 · Cited by 50
Tian, Y., Arai, E., Gotoh, M., Komiyama, M., Fujimoto, H., & Kanai, Y. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-772 · Cited by 49
Mendizabal, I., & Yi, S. V. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv449 · Cited by 52
Overman, M. J., Morris, V. K., Moinova, H., Manyam, G. C., Ensor, J., Lee, M. S., Eng, C., Kee, B. K., Fogelman, D. R., Shroff, R. T., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11317 · Cited by 50
Yeh, C., Chang, L.-Y., Lin, S., Chou, J., Hsieh, H., Zeng, L.-H., Chuang, S.-Y., Wang, H.-W., Dittner, C., Lin, C.-Y., et al. (2016) · Scientific Reports · doi:10.1038/srep31690 · Cited by 49
Interplay Between Inflammation and Epigenetic Changes in Cancer
Maiuri, A. R., & O’Hagan, H. M. (2016) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.09.002 · Cited by 48
Valdez, B., Li, Y., Murray, D., Liu, Y., Nieto, Y., Champlin, R., & Andersson, B. (2017) · OncoTarget · doi:10.18632/oncotarget.23386 · Cited by 47
Fanelli, G. N., Naccarato, A. G., & Scatena, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00569 · Cited by 53
Cancer stem cells in prostate cancer.
Moltzahn, F., & Thalmann, G. N. (2013) · PubMed Central · doi:10.3978/j.issn.2223-4683.2013.09.06 · Cited by 50
Epigenetics of lung cancer: a translational perspective
Quintanal-Villalonga, À., & Molina‐Pinelo, S. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00465-9 · Cited by 49
Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer
Pardo, J. C. T., de Porras, V. R., Gil, J., Pous, A. F., Puig‐Domingo, M., & Jordà, M. (2022) · Nutrients · doi:10.3390/nu14040851 · Cited by 55
High LET 56Fe ion irradiation induces tissue‐specific changes in DNA methylation in the mouse
Lima, F., Ding, D., Goetz, W., Yang, A. J., & Baulch, J. E. (2013) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21832 · Cited by 49
Epigenetic alterations of the Wnt signaling pathway in cancer: a mini review
Šerman, L., Martić, T. N., Šerman, A., & Vranić, S. (2014) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2014.4.205 · Cited by 49
Cunha, S., Lin, Y., Goossen, E. A., DeVette, C. I., Albertella, M. R., Thomson, S., Mulvihill, M. J., & Welm, A. L. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.010 · Cited by 48
Krøigård, A. B., Larsen, M. J., Lænkholm, A., Knoop, A. S., Jensen, J. D., Bak, M., Mollenhauer, J., Kruse, T. A., & Thomassen, M. (2015) · Oncotarget · doi:10.18632/oncotarget.3111 · Cited by 50
Cantariño, N., Musulén, E., Valero, V., Peinado, M. A., Perucho, M., Moreno, V. R., Forcales, S. V., Douet, J., & Buschbeck, M. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0034 · Cited by 49
Zhao, W., Ma, N., Wang, S., Mo, Y., Zhang, Z., Huang, G., Midorikawa, K., Hiraku, Y., Oikawa, S., Murata, M., et al. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0554-9 · Cited by 51
USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT/Skp2 pathway
Tan, Y., Zhou, G., Wang, X., Chen, W., & Gao, H. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4387 · Cited by 49
Chronic adolescent stress sex-specifically alters the hippocampal transcriptome in adulthood
Rowson, S. A., Bekhbat, M., Kelly, S. D., Binder, E. B., Hyer, M. M., Shaw, G. A., Bent, M. A. M., Hodes, G. E., Tharp, G. K., Weinshenker, D., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0321-z · Cited by 53
Su, J., Zhao, F., Gao, Z., Hou, Y., Li, Y., Duan, L., Lun, S., Yang, H., Li, J.-K., Dai, N., et al. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.152848 · Cited by 49
Understanding the complex pathogenesis of oral cancer: A comprehensive review
Georgaki, M., Theofilou, V. I., Pettas, E., Stoufi, E. D., Younis, R. H., Kolokotronis, A. E., Sauk, J. J., & Nikitakis, N. G. (2021) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2021.04.004 · Cited by 52
Metabolic Regulation of Epigenetic Modifications and Cell Differentiation in Cancer
Saggese, P., Sellitto, A., Martinez, C. A., Giurato, G., Nassa, G., Rizzo, F. M., Tarallo, R., & Scafoglio, C. (2020) · Cancers · doi:10.3390/cancers12123788 · Cited by 46
Metadata
- Authors
- Baylin, S. B., & Jones, P. A.
- Affiliations
- Johns Hopkins University (US)
- University of Southern California (US)
- Corresponding author
- Baylin, Stephen B.
- Jones, Peter A.
- Venue
- Nature Reviews Cancer
- Published
- 2011-09-23
- Volume
- 11
- Issue
- 10
- Pages
- 726-734
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC3307543
- OpenAlex
- W2041686632
- Cited by
- 2,871
- References
- 166
- Citations by year
- 2026: 105 · 2025: 107 · 2024: 130 · 2023: 148 · 2022: 179 · 2021: 207 · 2020: 175 · 2019: 209 · 2018: 192 · 2017: 233 · 2016: 241 · 2015: 248 · 2014: 288 · 2013: 231 · 2012: 171
- FWCI
- 20.15
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Entertainment Industry Foundation
- National Institutes of Health
- National Cancer Institute (R01CA043318, R37CA082422)
- National Institute of Environmental Health Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- cancer epigenome, DNA methylation, chromatin, epigenetic therapy, tumor markers, cancer diagnosis and prognosis, tumor progression, DNA packaging, epigenetic enzymes, cancer metabolism, epigenetic mutations
- MeSH terms
- Animals, Humans, Neoplasms, Genome, Epigenesis, Genetic, History, 20th Century, History, 21st Century, Translational Research, Biomedical, Epigenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
